McKnight’s Senior Living February 16, 2024
Haymarket Media

(HealthDay News) — Patient-performed rapid antigen tests (RATs) are reliable for COVID-19, with comparable sensitivity and specificity to clinician-performed RATs, according to a study published online Feb. 14 in Microbiology Spectrum.

Mary Jane E. Vaeth, from the Baltimore Convention Center Field Hospital, and colleagues conducted a single-center study to assess the accuracy of self-performed RATs for COVID-19. The self-administered BinaxNOW RATs were compared with clinician-performed RATs and against laboratory molecular testing as the gold standard.

The researchers found that 14.9% of the 953 participants were positive for severe acute respiratory syndrome coronavirus 2 as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Government Dedicates Nearly $200 Million to Contain US Bird Flu Outbreak
Bird Flu (H5N1) Explained: Well-Cooked Burgers Safe From Virus, Study Finds
This grim but revolutionary DNA technology is changing how we respond to mass disasters
KFF Health News' 'What the Health?': Bird Flu Lands as the Next Public Health Challenge
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success

Share This Article